Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome

Clinical trial NCT04213274 · WITHDRAWN

Trial details

NCT number: NCT04213274
Sponsor: R-Pharm Overseas, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Schnitzler Syndrome Urticarial Vasculitis With Monoclonal Immunoglobulin M Component, Schnitzler (Disorder)

Start date: 2023-05-01
Primary completion: 2023-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.